Epitomee Medical Ltd. engages in the development of ingestible therapeutic devices. It operates through the Medical Devices for Weight Loss and Medical Devices for the Introduction of Biological Drugs segments. The Medical Devices for Weight Loss segment develops a pill that causes satiety that helps weight loss. The Medical Devices for the Introduction of Biological Drugs segment includes medical devices packaged in capsules and taken by ingestion which are intended for the introduction of biological drugs. The company was founded by Shimon Eckhouse and Doron Marco on August 15, 2005 and is headquartered in Caesarea, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Epitomee Medical Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Epitomee Medical Ltd market cap is $29.74M.
What is the 52-week high for Epitomee Medical Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Epitomee Medical Ltd 52 week high is $0.9892 as of October 01, 2025.
What is the 52-week low for Epitomee Medical Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Epitomee Medical Ltd 52 week low is $0.9892 as of October 01, 2025.
What is Epitomee Medical Ltd stock price today?
Epitomee Medical Ltd stock price today is $0.9892.
What was Epitomee Medical Ltd stock price yesterday?
Epitomee Medical Ltd stock price yesterday was $1.02.
What is the PE ratio of Epitomee Medical Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Epitomee Medical Ltd’s P/E ratio is 89.93.
What is the Price-to-Book ratio of Epitomee Medical Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Epitomee Medical Ltd P/B ratio is 0.9602.
What is the 50-day moving average of Epitomee Medical Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Epitomee Medical Ltd 50-day moving average is $0.9892.
